BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31065964)

  • 21. Did outcomes improve in retroperitoneal sarcoma surgery?
    Cananzi FCM; Ruspi L; Sicoli F; Minerva EM; Quagliuolo V
    Surg Oncol; 2019 Mar; 28():96-102. PubMed ID: 30851921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS): A Report on 1007 Patients From the Multi-institutional Collaborative RPS Working Group.
    Gronchi A; Strauss DC; Miceli R; Bonvalot S; Swallow CJ; Hohenberger P; Van Coevorden F; Rutkowski P; Callegaro D; Hayes AJ; Honoré C; Fairweather M; Cannell A; Jakob J; Haas RL; Szacht M; Fiore M; Casali PG; Pollock RE; Raut CP
    Ann Surg; 2016 May; 263(5):1002-9. PubMed ID: 26727100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morbidity, mortality and temporal trends in the surgical management of retroperitoneal sarcoma: An ACS-NSQIP follow up analysis.
    Judge SJ; Lata-Arias K; Yanagisawa M; Darrow MA; Monjazeb AM; Kirane AR; Bold RJ; Canter RJ; Canter DJ
    J Surg Oncol; 2019 Sep; 120(4):753-760. PubMed ID: 31355444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contemporary reappraisal of the efficacy of adjuvant chemotherapy in resected retroperitoneal sarcoma: Evidence from a nationwide clinical oncology database and review of the literature.
    Datta J; Ecker BL; Neuwirth MG; Geha RC; Fraker DL; Roses RE; Karakousis GC
    Surg Oncol; 2017 Jun; 26(2):117-124. PubMed ID: 28577717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets.
    Gronchi A; Miceli R; Shurell E; Eilber FC; Eilber FR; Anaya DA; Kattan MW; Honoré C; Lev DC; Colombo C; Bonvalot S; Mariani L; Pollock RE
    J Clin Oncol; 2013 May; 31(13):1649-55. PubMed ID: 23530096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term outcome of combined modality therapy in retroperitoneal and deep-trunk soft-tissue sarcoma: analysis of prognostic factors.
    Youssef E; Fontanesi J; Mott M; Kraut M; Lucas D; Mekhael H; Ben-Josef E
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):514-9. PubMed ID: 12243830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A contemporary large single-institution evaluation of resected retroperitoneal sarcoma.
    Bremjit PJ; Jones RL; Chai X; Kane G; Rodler ET; Loggers ET; Pollack SM; Pillarisetty VG; Mann GN
    Ann Surg Oncol; 2014 Jul; 21(7):2150-8. PubMed ID: 24615180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Excellent local control with preoperative radiation therapy, surgical resection, and intra-operative electron radiation therapy for retroperitoneal sarcoma.
    Stucky CC; Wasif N; Ashman JB; Pockaj BA; Gunderson LL; Gray RJ
    J Surg Oncol; 2014 Jun; 109(8):798-803. PubMed ID: 24862926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of resection and outcome in patients with retroperitoneal sarcoma.
    Chiappa A; Zbar AP; Biffi R; Bertani E; Biella F; Viale G; Pace U; Pruneri G; Orecchia R; Lazzari R; Poldi D; Andreoni B
    ANZ J Surg; 2006 Jun; 76(6):462-6. PubMed ID: 16768769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Personalizing the approach to retroperitoneal soft tissue sarcoma: histology-specific patterns of failure and postrelapse outcome after primary extended resection.
    Gronchi A; Miceli R; Allard MA; Callegaro D; Le Péchoux C; Fiore M; Honoré C; Sanfilippo R; Coppola S; Stacchiotti S; Terrier P; Casali PG; Le Cesne A; Mariani L; Colombo C; Bonvalot S
    Ann Surg Oncol; 2015 May; 22(5):1447-54. PubMed ID: 25300609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of Resection for Recurrent or Residual Retroperitoneal Sarcoma After Failed Primary Treatment.
    Hamilton TD; Cannell AJ; Kim M; Catton CN; Blackstein ME; Dickson BC; Gladdy RA; Swallow CJ
    Ann Surg Oncol; 2017 Jan; 24(1):211-218. PubMed ID: 27554502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retroperitoneal sarcomas: patterns of care in advanced stages, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group.
    Toulmonde M; Bonvalot S; Ray-Coquard I; Stoeckle E; Riou O; Isambert N; Bompas E; Penel N; Delcambre-Lair C; Saada E; Lecesne A; Le Péchoux C; Blay JY; Piperno-Neumann S; Chevreau C; Bay JO; Brouste V; Terrier P; Ranchère-Vince D; Neuville A; Italiano A;
    Ann Oncol; 2014 Mar; 25(3):730-734. PubMed ID: 24496921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group.
    Stoeckle E; Coindre JM; Bonvalot S; Kantor G; Terrier P; Bonichon F; Nguyen Bui B;
    Cancer; 2001 Jul; 92(2):359-68. PubMed ID: 11466691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overall survival after resection of retroperitoneal sarcoma at academic cancer centers versus community cancer centers: An analysis of the National Cancer Data Base.
    Berger NG; Silva JP; Mogal H; Clarke CN; Bedi M; Charlson J; Christians KK; Tsai S; Gamblin TC
    Surgery; 2018 Feb; 163(2):318-323. PubMed ID: 28943041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensity modulated radiation therapy and surgery for Management of Retroperitoneal Sarcomas: a single-institution experience.
    Cosper PF; Olsen J; DeWees T; Van Tine BA; Hawkins W; Michalski J; Zoberi I
    Radiat Oncol; 2017 Dec; 12(1):198. PubMed ID: 29216884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Surgery and postoperative radiation therapy in primary retroperitoneal sarcomas: experience of the cancer centre Alexis-Vautrin].
    Fuks D; Verhaeghe JL; Marchal F; Guillemin F; Beckendorf V; Peiffert D; Leroux A; Rios M; Troufléau P; Marchal C
    Cancer Radiother; 2012 May; 16(3):194-200. PubMed ID: 22387193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined management of retroperitoneal sarcoma with dose intensification radiotherapy and resection: long-term results of a prospective trial.
    Smith MJ; Ridgway PF; Catton CN; Cannell AJ; O'Sullivan B; Mikula LA; Jones JJ; Swallow CJ
    Radiother Oncol; 2014 Jan; 110(1):165-71. PubMed ID: 24411227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multimodality local therapy for retroperitoneal sarcoma.
    Paryani NN; Zlotecki RA; Swanson EL; Morris CG; Grobmyer SR; Hochwald SN; Marcus RB; Indelicato DJ
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1128-34. PubMed ID: 21664065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors of retroperitoneal soft tissue sarcomas: analysis of 132 cases.
    Chen CQ; Yin L; Peng CH; Cai Y; Li YF; Zhao R; Zhou HJ; Li HW
    Chin Med J (Engl); 2007 Jun; 120(12):1047-50. PubMed ID: 17637220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of surgical quality for retroperitoneal sarcoma: Volume matters.
    Maurice MJ; Yih JM; Ammori JB; Abouassaly R
    J Surg Oncol; 2017 Nov; 116(6):766-774. PubMed ID: 28608360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.